Northwire Canada EditionThursday, October 15, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4% GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4%
Regulatory Neutral

GuideAI Health Corp. to Begin Trading on Cboe Canada Under the Symbol "GDAI"

AI-driven vascular disease detection moves to public markets, but execution and commercialization remain unproven.

By The Northwire Desk — AI Analysis Jun 29, 2026 · 08:00 GDAI NaN
Executive Summary
  • GuideAI Health Corp. has received final approval from Cboe Canada Inc. to list its common shares on the Cboe Canada exchange.
  • Trading under the ticker symbol "GDAI" is scheduled to commence at market open on June 29, 2026.
  • The company operates in healthcare technology, utilizing artificial intelligence to analyze routine CT scans for the early detection of peripheral vascular disease.
  • Management frames the listing as a milestone to scale the platform and expand access to diagnostic technology.
Material Impact
  • The announcement is a standard administrative and regulatory step for a company transitioning to or expanding its public market access.
  • No concurrent capital raise, valuation metrics, institutional anchor investors, or financial disclosures are included in the release.
  • Without details on share count, offering price, or immediate liquidity provisions, the listing itself does not alter the company's fundamental valuation or cash position.
  • The primary material impact is procedural: increased visibility, potential future access to public capital markets, and standard exchange compliance requirements.
GDAI · Price
Company Overview
  • GuideAI Health Corp. is a healthcare technology firm focused on artificial intelligence applications in medical imaging.
  • Core product: AI algorithms that analyze routine CT scans to identify peripheral vascular disease.
  • Target customers: Hospitals and radiology groups seeking earlier detection and more precise treatment planning.
  • Current stage: Pre-listing/pre-commercialization phase with no disclosed revenue or proven market penetration.
Read the original news release →